Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2411-2420 of 2808 for

Edit search filters
  1. Establishment of Preclinical Models from Patients with Gynecological Malignancies

    Rochester, MN, Scottsdale/Phoenix, AZ

  2. A Study of Rose Geranium in Sesame Oil Nasal Spray for Treating Established Chemotherapy and Targeted Therapy-Related Nasal Vestibulitis

    Rochester, MN

  3. A Study to Learn More About Experiences of Patients with Genetic Risk for Breast Cancer

    Jacksonville, FL

  4. Evaluating Mepitel in Post-mastectomy Patients and the Role of the Skin Microbiome in Radiation Dermatitis

    Eau Claire, WI, Rochester, MN

  5. Immune Response to Antigens

    Jacksonville, FL

  6. Pilot Study of PROS Monitoring

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma (Pap-Op): Prospective Assessment of HPV Associated Anogenital Pathology

    Rochester, MN

  8. A Study to Identify Novel High Quality Methylated DNA Markers in Renal Tumors

    Rochester, MN

  9. An Observational Study of Sub-populations from Cologuard Post-Approval Study (2014-01)

    Rochester, MN

  10. A Survey of Pheochromocytoma and Paraganglioma Patient Environment

    Rochester, MN

.

Mayo Clinic Footer